Pharmaceuticals

Anxo Pharmaceutical Co., Ltd.
8F-3, No. 206, Sec. 2, Nanjing E. Rd, Zhongshan Dist, Taipei 104, Taiwan
瑩碩生技醫藥股份有限公司
+886-2-2504-2121
+886-2-2508-4245

Generic drug manufacturer, in DM, CV, CNS, infection, respiratory, GI, ophthalmic, otic and dermatological therapeutic areas.

Has been granted 41 ANDA approvals, of which includes 13 bioequivants (company website, March 2017)

台北市南京東路2段206號8F-3
2003
– na –
Bora Pharmaceuticals Co., Ltd.
6F, No. 69, Xingai Rd, Neihu Dist, Taipei City 114, Taiwan
保瑞藥業股份有限公司
+886-2-27901555
+886-2-27906595

Covers the entire pharmaceutical supply chain from research and development to sales and distribution. Provides outsourced R&D and manufacturing services for domestic and multinational pharmaceutical companies. PIC/S certified.

台北市內湖區行愛路69號6F
– na –
BRIM Biotechnology, Inc.
8F, No. 1, Alley 30, Lane 358, Ruiguang Rd, Neihu Dist, Taipei 11492, Taiwan
全福生物科技股份有限公司
+886-2-2659-8586
+886-2-2659-8779

Virtually operating company, focusing on developing new drugs in various areas including oncology and infectious disease. Focusing on translational medicine stage of drug development, team surveys many small molecules, peptides, biologics, and platform technologies at the lead optimization stage. Projects are brought into BRIM through co-development partnerships or in-licensing deals, and development of the projects is conducted at global CROs and CMOs that fit the needs of the project. Once clinical proof of concept (POC) is reached, the projects are partnered out for further clinical development.

11492台北市內湖區瑞光路358巷30弄1號8F
2013
– na –
Caleb Pharmaceuticals, Inc.
No. 3 Gongye 5th Rd, Hukou Township, Hsinchu County, Taiwan
華健醫藥生技股份有限公司
+886-3-212-9300
+886-3-212-9307

Pharmaceutical and medical device technology development company.

Specialized in controlled-release drug delivery technology research and production of patch products for pharmaceutical and consumer applications.

新竹工業區新竹縣湖口鄉工業五路3號
1995
– na –
Center Laboratories, Inc.
7F, No. 3-2, Yuanqu St, Nangang Dist, Taipei 115, Taiwan
晟德大藥廠股份有限公司
+886-2-2655-8680
+886-2-2655-8380

Pharmaceutical manufacturer, specializing in oral liquid drugs. Certified PIC/S

115臺北市南港區園區街3-2號7F
1959
4123
TaiEx
China Chemical & Pharmaceutical Co., Ltd.
No. 23, Hsiang Yang Rd., Taipei 10046, Taiwan
中國化學製藥股份有限公司
+886-2-2312-4200
+886-2-2361-5143

Primarily generic pharmaceuticals. Strategy is to provide niche and high manufacturing complexity API and generic drugs, as well as 505(b)(2) class new drugs (new route of administration, new derivatives, new use, etc.).

Six manufacturing facilities in Taiwan.

Affiliates include:
Chunghwa Chemical Synthesis & Biotech Co., Ltd.: API manufacturer
Suzhou Chunghwa Chemical & Pharmaceutical Industrial Co., Ltd. (China)
Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd. (China)
Chunghwa Yuming Healthcare Co., Ltd. (drug distribution)
Chunghwa Senior Care Co., Ltd. (seniors health care services)
Phermpep Co., Ltd. (peptide-based products for health)
Tai Rung Development Co., Ltd. (packaging products, ampoules, etc.)

台北市中正區襄陽路23號
1952
1701
TaiEx
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
No. 1 Tunghsing St, Shulin, New Taipei City 23850, Taiwan
中化合成生技股份有限公司
+886-2-8684-3318

API manufacture for small and large molecule drugs.

Facilities consist of seven areas for fermentation, purification and chemical synthesis for production ranging from kilograms to multiple tons. Fermentation capacity ranges from 75L to 50,000L. Purification and synthesis ranging from 30L to 8,000L.

Subsidiary of China Chemical & Pharmaceutical Co., Ltd.

23850新北市樹林區東興街1號
1964
1762
TPEx
Easywell Biomedicals Inc.
2F-2, No. 9, Jhanye 1st Rd, Hsinchu Science Park, Hsinchu 30078, Taiwan
易威生醫科技股份有限公司
+886-3-666-9596
+886-3-666-9697

Three business units: Pharmaceuticals, regenerative medicine, and medical devices, particularly digital clinical thermometers

30078新竹市科學園區展業一路9號2F-2
1998
1799
TPEx
Everest Pharmaceutical Industrial Co., Ltd.
永勝藥品工業股份有限公司
+886-5-221-8686
+886-5-221-3383

Generic drug company.

嘉義縣頭橋工業區工業三路6-3號
1967
– na –
Foresee Pharmaceuticals Co., Ltd.
3F, No. 19-3, Sanchong Rd, Nangang Dist, Taipei 115, Taiwan
逸達生物科技股份有限公司
+886-2-2655-2658
+886-2-2655-2657

1. Rapid development and commercialization of new drugs using its proprietary drug delivery technology. Targeting indications through the 505(b)(2) regulatory pathway. Products under development are FP-001 (prostate cancer), FP-004 (opiate drug addiction), FP-002 (acromegaly), and FP-008 (diabetic retinopathy).

2. Rationally-designed small molecule candidates, designed through medicinal chemistry screening and lead optimization. Products currently under development are FP-025 (asthma / chronic obstructive pulmonary disease) and FP-020 (Alport syndrome).

New drugs in clinical trials are FP-001 LMIS 50mg (prostate cancer), currently in a multinational multi-center phase III registration study in the US, Europe and Taiwan, and FP-025 (a small molecule MMP-12 inhibitor for the treatment of asthma / chronic obstructive pulmonary disease), in a First-in-Human Phase I study in Taiwan.

Foresee Pharmaceuticals also has a US office.

115台北市南港區三重路19-3號3F
6576
TPEx